ABSTRACT
Penile cancer is rare in Western countries. High-risk patients are considered for prophylactic inguinal lymphadenectomy. For advanced disease, a triplet drug regimen consisting of bleomycin, methotrexate, and cisplatin is the most active combination tested so far. A 62-year-old man with penile cancer underwent partial penile amputation but presented 10 months later with inguinal nodal metastasis. He received three cycles of paclitaxel/carboplatin with marked clinical and radiologic (computed tomography and positron emission tomography) tumor regression. Later, complete resection of the inguinal nodal metastasis was performed. The paclitaxel/carboplatin combination has potential activity in penile cancer. Positron emission tomography may be used for screening of nodal metastases.
Subject(s)
Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Carboplatin/therapeutic use , Carcinoma, Squamous Cell/drug therapy , Lymphatic Metastasis/diagnostic imaging , Paclitaxel/therapeutic use , Penile Neoplasms/drug therapy , Antineoplastic Agents, Phytogenic/therapeutic use , Carcinoma, Squamous Cell/pathology , Combined Modality Therapy , Fluorodeoxyglucose F18 , Humans , Lymph Node Excision/methods , Lymph Nodes/diagnostic imaging , Lymph Nodes/pathology , Lymph Nodes/surgery , Lymphatic Metastasis/pathology , Male , Middle Aged , Penile Neoplasms/pathology , Penile Neoplasms/surgery , Penis/surgery , Remission Induction/methods , Survival Analysis , Tomography, Emission-ComputedABSTRACT
We report on a case of a 67 year old male who had a cyst in the seminal vesicle region on sonography. The computed tomography and magnetic resonance imaging findings included a seminal vesical cyst with an intracystic tumor associated with an ipsilateral renal agenesis and are demonstrated. Postoperatively the diagnosis of an intracystic papillary adenoma in a seminal vesicle cyst was made histologically.
